Accessibility
Animation
Accessibility

Poster

Cell proliferation as a biomarker for response to immune checkpoint inhibitors in highly inflamed renal cell carcinoma (RCC)

August 2, 2019

Published in: ASCO-SITC Clinical Immuno-Oncology Symposium - 2019